You searched for: prostate type genomics

Prostate Genomics | Life Science Summit 2025

CEO Fredrik Rickman presents Prostatype Genomics at Life Science Summit 2025.

Prostatype Genomics lifts the lid on new product

Prostatype Genomics receives SEK 11,5 million from warrants

Prostatype Genomics takes the next step in the US – starts billing insurance companies

Since the second quarter of 2024, Prostatype has been used clinically by a growing number of urologists in the United States. The aim has been...

Prostatype Genomics updates on Medicare application

Prostatype Genomics begins invoicing in the US

Prostatype focuses commercialization through issuance

Prostatype Genomics' prognostic tool provides a more reliable risk classification in prostate cancer and a safer treatment decision for each patient, which...

Prostatype Genomics CEO on the commercialization strategy

In an interview, Prostatype Genomics CEO Fredrik Persson explains why the company's genetic test is needed for patients with confirmed prostate cancer. In addition...

Prostatype CEO: "Our US project is associated with low risks"

Prostatype Genomics is in the commercialization phase of its prostate cancer genetic test. The main focus is on the American market, where it...

BioStock Investor Pitch: Prostate Genomics

Prostatype Genomics has begun commercialization of its prognostic genetic test Prostatype for confirmed prostate cancer. Going forward, the company will aim to...

Prostatype's CEO on the commercial venture

Solna-based Prostatype Genomics has developed a diagnostic tool for assessing prostate cancer patients. The company is just at the start of its...

Prostatype bets on the US with an IPO

Prostatype Genomics had its commercial breakthrough last year. After hospitals reopened after the pandemic, the company was able to reap the...